Document Detail

Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines.
MedLine Citation:
PMID:  22919249     Owner:  NLM     Status:  MEDLINE    
AIM: To investigate the cytotoxic effects of spray-dried extracts of Phyllanthus niruri in combination with cisplatin on two cancer cell lines.
METHODS: Colorectal carcinoma (HT29) and human hepatocellular carcinoma (HepG2) cells were treated with spray-dried extracts of Phyllanthus niruri (SDEPN) either alone or in combination with cisplatin at different concentrations (0.5 mg/mL and 1 mg/mL) for 4 h and 24 h. To verify and quantify cancer cells treated with these products as well as identify the cell cycle stage and cell viability, we stained the cells with propidium iodide and assessed them by flow cytometry. The percentage of cells in different cell cycle phases was quantified and data were expressed as histograms. Significant differences between groups were determined using analysis of variance and Bonferroni's test, as indicated. A value of P < 0.05 was considered to be statistically significant.
RESULTS: SDEPN had significantly different cytotoxic effects on HT29 (2.81 ± 0.11 vs 3.51 ± 1.13, P > 0.05) and HepG2 (5.07 ± 0.3 vs 15.9 ± 1.04, P < 0.001) cells when compared to control cells for 4 h. SDEPN also had significantly different cytotoxic effects on HT29 (1.91 ± 0.57 vs 4.53 ± 1.22, P > 0.05) and HepG2 (14.56 ± 1.6 vs 35.67 ± 3.94, P < 0.001) cells when compared to control cells for 24 h. Both cell lines were killed by cisplatin in a dose-dependent manner compared to control cells (HepG2 cells for 4 h: 10.78 ± 1.58 vs 53.89 ± 1.53, P < 0.001; 24 h: 8.9 ± 1.43 vs 62.78 ± 1.87, P < 0.001 and HT29 cells for 4 h: 9.52 ± 0.913 vs 49.86 ± 2.89, P < 0.001; 24 h: 11.78 ± 1.05 vs 53.34 ± 2.65, P < 0.001). In HT29 cells, pretreatment with SDEPN and subsequent treatment with cisplatin resulted in a greater number of cells being killed (12.78 ± 1.01 vs 93.76 ± 1.6, P < 0.001). HepG2 cells showed significant cell killing with treatment with SDEPN when combined with cisplatin (12.87 ± 2.78 vs 78.8 ± 3.02, P < 0.001).
CONCLUSION: SDEPN is selectively toxic against two cancer cell lines. Moreover, SDEPN in combination with cisplatin induces a synergistic increase in the cell death of both HT29 and HepG2 cells.
Raimundo Fernandes Araújo; Luiz Alberto Lira Soares; Cínthia Raquel da Costa Porto; Ranniere Gurgel Furtado de Aquino; Hugo Gonçalo Guedes; Pedro Ros Petrovick; Tatiane Pereira de Souza; Aurigena Antunes Araújo; Gerlane Coelho Bernardo Guerra
Related Documents :
12060069 - Planarian fibroblast growth factor receptor homologs expressed in stem cells and cephal...
8218629 - Embryonic modulation of basic fibroblast growth factor in the rat uterus.
7675039 - Vanadium derivatives act as growth factor--mimetic compounds upon differentiation and p...
6368369 - Growth of preadipocyte cell lines and cell strains from rodents in serum-free hormone-s...
21739529 - Pax7 expressing cells contribute to dermal wound repair; regulating scar size through a...
19635129 - A dictyostelium chalone uses g proteins to regulate proliferation.
22448289 - Overactivation of notch1 signaling induces ectopic hair cells in the mouse inner ear in...
22926799 - Developmental stage-specific contribution of lgr5+ cells to basal and luminal epithelia...
21637339 - Cell entry and trafficking of human adenovirus bound to blood factor x is determined by...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  18     ISSN:  2219-2840     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-24     Completed Date:  2013-04-04     Revised Date:  2014-05-20    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  4162-6168     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / pharmacology
Apoptosis / drug effects
Carcinoma, Hepatocellular / pathology*
Cell Cycle
Cell Line, Tumor
Cell Proliferation / drug effects*
Cell Survival / drug effects
Cisplatin / pharmacology*
Colorectal Neoplasms / pathology*
Drug Synergism
Drug Therapy, Combination
Liver Neoplasms / pathology*
Plant Extracts / pharmacology*
Reg. No./Substance:
0/Antineoplastic Agents; 0/Plant Extracts; Q20Q21Q62J/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intrahepatic expression of genes related to metabotropic receptors in chronic hepatitis.
Next Document:  Sensitivity of the suspected blood indicator: an experimental study.